Evofosfamide not checked

ImmunoGenesis · TH-302

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
1 active
7 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Evofosfamide administered on Days 1 and 8 of Cycles 1, 2, and 3.”In the company’s words, NCT06782555 on ClinicalTrials.gov
Tested for
Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer
Main trialPhase 1/2
“The purpose of this Phase 1/2 study is to test the overall safety, tolerability, and effectiveness of the combination investigational drugs evofosfamide, zalifrelimab, and balstilimab in treating advanced or metastatic castration-resistant prostate cancer, pancreatic cancer, and human papilloma virus (HPV)-negative squamous cell carcinoma of the head and neck (SCCHN).”In the company’s words, NCT06782555 on ClinicalTrials.gov
Other names
TH-302 · HAP · hypoxia activated prodrug
Given with
Gemzar (Lilly)Other companies’ drugs in its trials

Other drugs for Metastatic Prostate Cancer

All 193 drugs for Metastatic Prostate Cancer

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials7

TrialPhaseCompletesWhat it tests
Phase 1/2Active, not recruiting Oct 2027 A Study of Evofosfamide in Combination With Zalifrelimab and Balstilimab
Phase 3Completed Feb 2016 Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Phase 2Completed Sep 2013 Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma
Phase 2Terminated Sep 2015 A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma
Phase 2Terminated Apr 2016 Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
Phase 1/2Completed Jul 2013 Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
Phase 1Terminated Sep 2015 Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Evofosfamide

Following is part of Solo: you see every change to Evofosfamide the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in